Literature DB >> 17635527

Characteristics of brain tumour-associated headache.

C J Schankin1, U Ferrari, V M Reinisch, T Birnbaum, R Goldbrunner, A Straube.   

Abstract

Eighty-five brain tumour patients were examined for further characteristics of brain tumour-associated headache. The overall prevalence of headache in this population was 60%, but headache was the sole symptom in only 2%. Pain was generally dull, of moderate intensity, and not specifically localized. Nearly 40% met the criteria of tension-type headache. An alteration of the pain with the occurrence of the tumour was experienced by 82.5%, implying that the pre-existing and the brain tumour headaches were different. The classic characteristics mentioned in the International Classification of Headache Disorders (worsening in the morning or during coughing) were not found; this might be explained by the patients not having elevated intracranial pressure. Univariate analysis revealed that a positive family history of headache and the presence of meningiomas are risk factors for tumour-associated headache, and the use of beta-blockers is prophylactic. Pre-existing headache was the only risk factor according to logistic regression, suggesting that patients with pre-existing (primary) headache have a greater predisposition to develop secondary headache. Dull headache occurs significantly more often in patients with glioblastoma multiforme, and pulsating headache in patients with meningioma. In our study, only infratentorial tumours were associated with headache location, and predominantly with occipital but rarely frontal pain.

Entities:  

Mesh:

Year:  2007        PMID: 17635527     DOI: 10.1111/j.1468-2982.2007.01368.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  19 in total

Review 1.  Neuroimaging in Secondary Headache Disorders.

Authors:  Priyanka Chaudhry; Deborah I Friedman
Journal:  Curr Pain Headache Rep       Date:  2015-07

2.  Headaches in children with craniopharyngioma.

Authors:  Raja B Khan; Thomas E Merchant; Frederick A Boop; Robert A Sanford; Davonna Ledet; Arzu Onar-Thomas; Larry E Kun
Journal:  J Child Neurol       Date:  2012-11-08       Impact factor: 1.987

Review 3.  Unusual headaches in the elderly.

Authors:  Cynthia C Bamford; MaryAnn Mays; Stewart J Tepper
Journal:  Curr Pain Headache Rep       Date:  2011-08

Review 4.  [Diagnosis and therapy of chronic headaches].

Authors:  A May; T P Jürgens
Journal:  Nervenarzt       Date:  2010-08       Impact factor: 1.214

5.  Impact of GP direct-access computerised tomography for the investigation of chronic daily headache.

Authors:  Graeme C Simpson; Kirsten Forbes; Evelyn Teasdale; Alok Tyagi; Celestine Santosh
Journal:  Br J Gen Pract       Date:  2010-12       Impact factor: 5.386

6.  Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry.

Authors:  Birthe Krogh Rasmussen; Steinbjørn Hansen; René J Laursen; Michael Kosteljanetz; Henrik Schultz; Bente Mertz Nørgård; Rikke Guldberg; Kim Oren Gradel
Journal:  J Neurooncol       Date:  2017-08-31       Impact factor: 4.130

Review 7.  Assessment of acute headache in adults - what the general physician needs to know.

Authors:  Krishna Chinthapalli; Anne-Marie Logan; Rohit Raj; Niranjanan Nirmalananthan
Journal:  Clin Med (Lond)       Date:  2018-10       Impact factor: 2.659

8.  [Migraine recurrence due to intracranial metastasis of a thyroid carcinoma].

Authors:  C J Schankin; J Wagner; M Elstner; V M Reinisch; A Straube
Journal:  Nervenarzt       Date:  2008-04       Impact factor: 1.214

Review 9.  [Headache in the elderly].

Authors:  V M Reinisch; C J Schankin; J Felbinger; P Sostak; A Straube
Journal:  Schmerz       Date:  2008-02       Impact factor: 1.107

Review 10.  Mechanics, malignancy, and metastasis: the force journey of a tumor cell.

Authors:  Sanjay Kumar; Valerie M Weaver
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.